RxDoctor Payments Data

Tammy Murphy, NP

Family · Upper Sandusky, OHNPI 1760767776

Payments from drug & device makers

$279in general payments, 2019–2025

Across 15 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$36
  • Travere Therapeutics, Inc.$34
  • Boehringer Ingelheim$32
  • Johnson & Johnson$24
  • AbbVie$22
  • Dexcom, Inc.$22
  • plus $110 from 6 others

What the payments were for

  • Food & beverage$24588%
  • Education$3412%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$279 in reported general payments places this provider in the 45th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$17,202
Medicare patients
126
Services billed
720

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin29$25,667
Potassium Citrate ErPotassium Citrate59$8,262
Cinacalcet Hcl25$7,151
FarxigaDapagliflozin Propanediol12$6,463
Calcitriol312$4,790
Bumetanide73$4,529
Nifedipine ErNifedipine118$4,296
Allopurinol405$3,359
Losartan Potassium278$2,676
Potassium Chloride87$2,056
Midodrine Hcl14$1,707
Febuxostat15$1,635
Sevelamer Carbonate15$1,515
Calcium Acetate34$1,441
Spironolactone111$1,100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$32$25,66729 claims
AstraZenecaFarxiga$19$6,46312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 6,812 family providers in Ohio.

Other family in Upper Sandusky

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →